Price T Rowe Associates Inc Praxis Precision Medicines, Inc. Transaction History

Price T Rowe Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.8 - $4.98 $6,040 - $37,599	-7,550 Reduced 15.75%	40,383 $33,000
Q4 2022 Feb 14, 2023	BUY	$1.88 - $36.45 $23,169 - $449,209	12,324 Added 34.61%	47,933 $114,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $37.95 $13,387 - $203,222	-5,355 Reduced 13.07%	35,609 $81,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $11.34 $23,514 - $152,375	13,437 Added 48.81%	40,964 $100,000
Q1 2022 May 16, 2022	BUY	$10.21 - $20.29 $8,076 - $16,049	791 Added 2.96%	27,527 $281,000
Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $100,157 - $137,388	5,976 Added 28.79%	26,736 $527,000
Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $272,994 - $468,345	20,760 New	20,760 $384,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.